Navigating the realm of end-of-life care and access to medications like Pentobarbital in New South Wales, Australia, requires a careful grasp of the intricate legal structure. Currently, Pentobarbital does not have a recognized place on the Pharmaceutical Benefits Scheme (PBS) and is therefore not regularly prescribed by healthcare professionals. I